Cite
A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study.
MLA
Evon, Donna M., et al. “A Comprehensive Assessment of Patient Reported Symptom Burden, Medical Comorbidities, and Functional Well Being in Patients Initiating Direct Acting Antiviral Therapy for Chronic Hepatitis C: Results from a Large US Multi-Center Observational Study.” PLoS ONE, vol. 13, no. 8, Aug. 2018, pp. 1–26. EBSCOhost, https://doi.org/10.1371/journal.pone.0196908.
APA
Evon, D. M., Stewart, P. W., Amador, J., Serper, M., Lok, A. S., Sterling, R. K., Sarkar, S., Golin, C. E., Reeve, B. B., Nelson, D. R., Reau, N., Lim, J. K., Reddy, K. R., Di Bisceglie, A. M., & Fried, M. W. (2018). A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PLoS ONE, 13(8), 1–26. https://doi.org/10.1371/journal.pone.0196908
Chicago
Evon, Donna M., Paul W. Stewart, Jipcy Amador, Marina Serper, Anna S. Lok, Richard K. Sterling, Souvik Sarkar, et al. 2018. “A Comprehensive Assessment of Patient Reported Symptom Burden, Medical Comorbidities, and Functional Well Being in Patients Initiating Direct Acting Antiviral Therapy for Chronic Hepatitis C: Results from a Large US Multi-Center Observational Study.” PLoS ONE 13 (8): 1–26. doi:10.1371/journal.pone.0196908.